Sequential Neurofeedback via EEG Lead COV Ranking

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current low energy neurofeedback treatments do not optimize the order of treatment at different EEG leads, potentially limiting therapeutic efficiency.

Innovation Solution

The method involves attaching EEG leads to the patient's scalp, acquiring baseline EEG measurements, calculating the Fast Fourier Transform (FFT) for multiple time segments, determining the Coefficient of Variance (COV) for each lead, and providing neurofeedback in the sequence of higher to lower COV, selecting activity parameters based on predetermined criteria, and treating the sites with the greatest number of EEG sites meeting selection criteria.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Area of stationary object

If neurofeedback treatment is provided at multiple EEG leads simultaneously, then treatment coverage is improved, but treatment efficiency is reduced due to lack of optimized sequencing

Engineering Contradiction:
Improvetreatment coverageVSAvoidtreatment efficiency
Core Design Contradiction:
Area of stationary objectVSProductivity

Solution Approach 1:

The patent segments the neurofeedback treatment into discrete sequential steps, where treatment is delivered to individual EEG leads one at a time rather than simultaneously. The system divides the multi-lead treatment into ordered segments based on COV calculations, treating each lead in sequence from highest to lowest COV value.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent performs preliminary analysis by calculating the Coefficient of Variance (COV) for each EEG lead before delivering treatment. This preliminary action ranks the leads in order of treatment priority, allowing the system to optimize the treatment sequence in advance based on measured brain activity variability.

Inventive Principle:
Principle #10Preliminary action

2Device complexity

If treatment sequence is randomized or arbitrary, then device complexity is reduced, but measurement precision is lost in determining effective treatment order

Engineering Contradiction:
Improvetreatment protocol complexityVSAvoidtreatment sequence optimization
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent implements feedback by continuously monitoring EEG signals and calculating COV values for each lead. This feedback mechanism uses the measured variability in brain activity to dynamically determine and adjust the treatment sequence, ensuring that leads with higher variability are treated first.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The patent changes the treatment parameter from a fixed arbitrary sequence to a dynamic sequence based on COV values. By using COV as a quantitative parameter to rank leads, the system transforms the treatment order from static to adaptive, optimizing treatment based on real-time brain activity measurements.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS8239014B2Sequential low energy neurofeedback treatment
Publication Date: 2012.08.07 OCHSLABS LLC
  • US8239014B2 patent drawing
  • US8239014B2 patent drawing
  • US8239014B2 patent drawing

AI summary

The dominant brain wave frequencies of a patient are measured by an electroencephalogram (EEG) with a plurality of leads over the head and scalp. In a process for low energy neuro-feedback, the therapeutically beneficial low power RF field is sequentially applied via the same at a different frequency, which is generally offset from the dominant frequency by 5 to 20 Hz. The order of applying these low power stimuli to the different leads is optimized based on the activity observed at each lead and its variation over time. Leads positions having a greater Coefficient of Variation are treated first.